Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joanna Rymuza"'
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundTherapy with intravenous glucocorticoids (GCs) is associated with various side effects, however, the impact on bone remains elusive. Trabecular bone score (TBS) is a diagnostic tool providing information on bone microarchitecture based on i
Externí odkaz:
https://doaj.org/article/21c747c7857c42a4beb13f04392bcb4b
Publikováno v:
Journal of Medical Science, Vol 90, Iss 2 (2021)
Introduction. Dysthyroid optic neuropathy (DON) is a severe complication of Graves’ orbitopathy (GO). Treatment of DON should involve immediate administration of intravenous methylprednisolone (ivMP) in very high doses. It is recommended to include
Externí odkaz:
https://doaj.org/article/c4d4d4278f854bff940974fe2f47e9c1
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 17; Pages: 5005
Background: Treatment with glucocorticoids (GCs) is associated with side effects. In contrast to the well-known negative impact on bone tissue exerted by oral GCs, few data are available regarding intravenous GCs. We investigated the influence of int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b41c9710035e87497500bcc43ff8e8
https://pubmed.ncbi.nlm.nih.gov/36078937
https://pubmed.ncbi.nlm.nih.gov/36078937
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 8; Pages: 2068
Background: Dysthyroid optic neuropathy (DON) is a sight-threatening complication of Graves’ orbitopathy (GO). Treatment of DON consists of the urgent administration of intravenous methylprednisolone (ivMP) in very high doses followed by orbital de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071beae6c9d725e0989fe9990ae50ca5
Publikováno v:
Journal of Medical Science, Vol 90, Iss 2 (2021)
Introduction. Dysthyroid optic neuropathy (DON) is a severe complication of Graves’ orbitopathy (GO). Treatment of DON should involve immediate administration of intravenous methylprednisolone (ivMP) in very high doses. It is recommended to include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31e14a31a2e52da98fe920815ffd458
https://jms.ump.edu.pl/index.php/JMS/article/view/519
https://jms.ump.edu.pl/index.php/JMS/article/view/519
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 47(279)
High and very high doses of intravenous methylprednisolone (IVMP) administered in pulses are the first-line treatment for active, moderateto- severe, as well as sight-threatening Graves' orbitopathy (GO). However, glucocorticoid therapy is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec0462468d7ab1cb60656362937336d6
https://pubmed.ncbi.nlm.nih.gov/31557136
https://pubmed.ncbi.nlm.nih.gov/31557136